[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601566":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":25,"responsibleParty":35,"collaborators":25,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":25,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":61,"whyStopped":25,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":25},{"fullName":5,"class":6},"Henan Provincial People's Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Oliceridine group","EXPERIMENTAL","After entering the room, the patient was intravenously injected with oselidine at a dose of 0.08mg\u002Fkg during anesthesia induction",[13],"Drug: Oliceridine",{"label":15,"type":16,"description":17,"interventionNames":18},"Sufentanil group","ACTIVE_COMPARATOR","After the patient entered the room, sufentanil was injected intravenously during anesthesia induction with a dose of 0.4 μ g\u002Fkg",[19],"Drug: Sulfentanil",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DRUG","Oliceridine",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Sulfentanil",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Ningning Fu","CONTACT","8618790658707","736508728@qq.com",{"type":36,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100601566","efficacy-of-oxalidine-and-sufentanil-in-strabismus-correction-100601566",false,"NCT07112157","Efficacy of Oxalidine and Sufentanil in Strabismus Correction","Efficacy of Oxalidine and Sufentanil in Strabismus Correction: a Non Inferiority Trial","strabismus","Inclusion Criteria:\n\n* The patients to be treated with strabismus correction under general anesthesia are 3-60 years old, regardless of gender.\n\nThe American Society of anesthesiologists (ASA) classification is Ⅰ - Ⅱ. Patients or their guardians (for child patients) voluntarily participated in the trial and signed the informed consent form with informed consent.\n\nExclusion Criteria:\n\n* Those who are allergic to oxalidine, sufentanil or any of the ingredients in their preparations.\n\nPatients with severe heart, liver, kidney and other important organ dysfunction.\n\nHave a history of epilepsy or central nervous system disease. Other opioid analgesics were used within 48 hours before operation. Pregnant or lactating women. Patients with mental disorders who are unable to cooperate to complete the test related assessment.",true,"ALL","3 Years","60 Years",{"count":50,"type":51},290,"ESTIMATED","INTERVENTIONAL",[54],"NA","The purpose of this study is to compare the anesthetic effect of oxalidine and sufentanil in strabismus surgery through a non inferiority test, including analgesic efficacy, intraoperative hemodynamic stability, postoperative recovery quality and the incidence of adverse reactions. . This study will provide a new evidence-based basis for the application of opioids in ophthalmic short surgery, and may improve the perioperative experience of patients.",[57],"Strabismus Surgery",[59,60],"strabismus surgery","analgesia","NOT_YET_RECRUITING","2025-08-01",{"date":64,"type":65},"2025-08-08","ACTUAL",{"date":67,"type":51},"2025-08",{"date":69,"type":51},"2026-08",{"name":5,"class":6}]